CIK 0001636282
- Large accelerated filer
Spyre Therapeutics, Inc.
Sign in to watch- Ticker
- SYRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464312787
- Phone
- +1 617-651-5940
- Business address
- 221 CRESCENT STREET, BUILDING 23, SUITE 105, WALTHAM, MA, 02453
- Former names
- Aeglea BioTherapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $12,349,597
- in 6 filings, $12.3M under 10b5-1 plans
Net −$12,349,597. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 21 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-23 | Hanley Jr. Michael Conick Chief Business Officer | Grant or award · Employee Stock Option (right to buy) | +500,000 | 500,000 | ||
| 2022-08-23 | Hanley Jr. Michael Conick Chief Business Officer | Grant or award · Employee Stock Option (right to buy) | +130,000 | 130,000 | ||
| 2022-06-08 | Hanley Jr. Michael Conick Chief Commercial Officer | Purchase | +28,200 | $0.71 | $20K | 36,200 |
| 2022-02-17 | Hanley Jr. Michael Conick Chief Commercial Officer | Grant or award · Employee Stock Option (right to buy) | +160,000 | 160,000 | ||
| 2021-02-17 | Hanley Jr. Michael Conick Chief Commercial Officer | Grant or award · Employee Stock Option (right to buy) | +135,000 | 135,000 | ||
| 2020-02-14 | Hanley Jr. Michael Conick Chief Commercial Officer | Grant or award · Employee Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2019-10-21 | Hanley Jr. Michael Conick Chief Commercial Officer | Grant or award · Employee Stock Option (right to buy) | +130,000 | 130,000 |
Page 1 of 1 · 7 trades